[1] Luo Y, Li N, Cong X, et al. Pathogenicity and genomic characterization of a pseudorabies virus variant isolated from Bartha-K61-vaccinated swine population in China[J]. V Microbiol, 2014, 174(1-2): 107-115.
[2] Yuan JF, Zhang SJ, Jafer O, et al. Global transcriptional response of pig brain and lung to natural infection by pseudorabies virus[J]. BMC Microbiol, 2009, 9(1): 1-11.
[3] Liu SN, Luan JY, Zhang Y, et al. Construction of 4T1 CXCR4 knockout gene stable strain using CRISPR/Cas9 gene editing system[J]. Acta Anatomica Sinica, 2018, 49(3):303-308. (in Chinese)
刘思念,栾靖旸,张彦,等. CRISPR/Cas 9系统构建4T1细胞CXCR4基因敲除稳定细胞株[J]. 解剖学报,2018,49(3):303-308.
[4] Ma H, Yang W, Zhang L, et al. Interferon-alpha promotes immunosuppression through IFNAR1/STAT1 signalling in head and neck squamous cell carcinoma[J]. Br J Cancer, 2019, 120(3): 317-330.
[5] Qian J, Zheng H, Huangfu WC, et al. Pathogen recognition receptor signaling accelerates phosphorylation-dependent degradation of IFNAR1[J]. PLoS Pathog, 2011, 7(6)e1002065.
[6] Chang-Long He, Ming Liu, Zhao-Xia Tan, et al. Hepatitis C virus core protein-induced miR-93-5p upregulation inhibits interferon signaling pathway by targeting IFNAR1[J]. World J Gastroenterol, 2018, 24(2): 226-236.
[7] Bhattachary S, Kattinski KV, Reichert M, et al. Triggering ubiquitination of IFNAR1 protects tissues from inflammatory injury[J]. EMBO Mol Med, 2014, 6(3): 384-397.
[8] Zhou J, Smith DK, Poon VK, et al. A non-synonymous single nucleotide polymorphism in IFNAR1 affects susceptibility to chronic hepatitis B virus infection[J]. J Viral Hepart, 2009, 16(1): 45-52.
[9] Song J, Ji X, Liu WB, et al. Expression of type Ⅰ interferon receptor in condyloma acuminatum and peripheral blood mononuclear cells[J]. Chinese Journal of Dermatology and Venereology, 2010, 24(10): 909-911. (in Chinese)
宋军,吉玺,刘雯蓓,等.Ⅰ型干扰素受体在尖锐湿疣皮损及外周血单核细胞中的表达[J].中国皮肤性病学杂志,2010,24(10):909-911.
|